Clari Vest Asset Management LLC Chinook Therapeutics, Inc. Transaction History

Clari Vest Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	SELL	$21.53 - $26.8 $2,669 - $3,323	-124 Reduced 0.4%	31,060 $719,000
Q4 2022 Feb 14, 2023	SELL	$18.63 - $27.35 $7,694 - $11,295	-413 Reduced 1.31%	31,184 $817,000
Q3 2022 Nov 10, 2022	BUY	$17.51 - $23.37 $717 - $958	41 Added 0.13%	31,597 $621,000
Q2 2022 Aug 12, 2022	BUY	$12.59 - $18.8 $397,290 - $593,252	31,556 New	31,556 $552,000
Q1 2022 May 04, 2022	SELL	$12.02 - $16.69 $632,937 - $878,845	-52,657 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$10.69 - $16.83 $9,621 - $15,146	-900 Reduced 1.68%	52,657 $859,000
Q3 2021 Nov 08, 2021	SELL	$11.5 - $14.86 $3,450 - $4,458	-300 Reduced 0.56%	53,557 $684,000
Q2 2021 Aug 09, 2021	BUY	$13.6 - $18.98 $732,455 - $1.02 Million	53,857 New	53,857 $761,000

234K

Ticker KDNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,896,300
Description
Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.